Longevity & Anti-Aging Peptides: Research Evidence Guide
Longevity-focused peptides like Epithalon (Epitalon), MOTS-c, and NAD+ precursors are studied in the context of aging biology and cellular health. Evidence in this category is generally preliminary, with most research limited to animal models and cell culture studies.
This is the peptide category most burdened by marketing hype and the least supported by rigorous human data. Epithalon research, originating primarily from Russian institutions, focuses on telomerase activation and epiphyseal function, but the trials cited most frequently online were small, methodologically limited, and have not been independently replicated. MOTS-c is a mitochondrial-derived peptide with interesting preclinical data in metabolic regulation, but human trials remain preliminary. No longevity peptide has demonstrated extension of maximum lifespan in humans — the claims you see in marketing materials extrapolate from cell and animal data in ways that are not scientifically defensible. Patients interested in this category should understand that "longevity" as a measurable clinical endpoint requires decades of follow-up, and current evidence is nowhere near this standard.
8 compounds in this category
Key Takeaways
- No longevity peptide has demonstrated human lifespan extension in controlled trials
- Most evidence derives from animal models and cell culture studies
- Epithalon claims rest on unreplicated Russian research
- MOTS-c has mechanistically interesting preclinical data but limited human evidence
- Marketing in this space frequently overstates the strength of available data
Compounds in This Category
CJC-1295CJC-1295 DAC, CJC-1295 without DAC
A growth hormone-releasing hormone (GHRH) analog studied for its ability to increase growth hormone and IGF-1 levels.
IpamorelinNNC 26-0161
A selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin.
GHK-CuCopper Peptide, Glycyl-L-histidyl-L-lysine:copper(II)
A naturally occurring copper-binding tripeptide with research supporting skin remodeling, wound healing, and anti-aging properties.
SermorelinGeref, GHRH(1-29)NH2
A growth hormone-releasing hormone analog with a long history of clinical use for GH deficiency diagnosis and therapy.
EpithalonEpitalon, Epithalone
A tetrapeptide studied for its potential to activate telomerase and extend cellular lifespan, primarily in Russian research.
MOTS-cMitochondrial Open Reading Frame of the 12S rRNA-c
A mitochondria-derived peptide that targets the AMPK pathway, studied for metabolic regulation and exercise mimicry.
MK-677Ibutamoren, Nutrobal
An oral ghrelin mimetic (not a peptide) that stimulates growth hormone release. Has extensive human data but has not achieved FDA approval.
NAD+Nicotinamide Adenine Dinucleotide, NAD
A coenzyme critical for cellular energy and DNA repair. Not technically a peptide, but commonly discussed alongside peptide therapies in the longevity space.
Frequently Asked Questions
Can peptides actually extend lifespan?
No peptide has demonstrated human lifespan extension in controlled trials. Animal and cellular data exist, but these do not translate reliably to human aging outcomes.
What does Epithalon actually do?
Epithalon appears to activate telomerase in some cell models and has shown pineal-related effects in rat studies. Human trial evidence is limited and mostly unreplicated.
Is MOTS-c a proven anti-aging compound?
MOTS-c is a mitochondrially-derived peptide with preclinical interest in metabolic and aging biology. Human trial data is preliminary; it should not be marketed as proven.
How should I evaluate longevity peptide claims?
Ask whether the evidence cited is from randomized human trials, observational studies, or preclinical research. Most longevity-peptide marketing cites the weakest evidence tier.
Are these peptides safe long-term?
Long-term human safety data is limited for every compound in this category. Telomerase-active compounds in particular require theoretical cancer-risk evaluation.